Cargando…
PlpE Epitopes of Pasteurella multocida Fusion Protein as Novel Subunit Vaccine Candidates
BACKGROUND: Pasteurella multocida is the causative agent of many diseases. Antimicrobial treatment disadvantages highlight the need to find other possible ways such as prophylaxis to manage infections. Current vaccines against this agent include inactivated bacteria, live-attenuated bacteria, and no...
Autores principales: | Mostaan, Saied, Ghasemzadeh, Abbas, Ehsani, Parastoo, Sardari, Soroush, Shokrgozar, Mohammad Ali, Abolhassani, Mohsen, Brujeni, Gholamreza Nikbakht |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532835/ https://www.ncbi.nlm.nih.gov/pubmed/33072655 http://dx.doi.org/10.4103/abr.abr_245_19 |
Ejemplares similares
-
In silico Analysis of Pasteurella multocida PlpE Protein Epitopes As Novel Subunit Vaccine Candidates
por: Mostaan, Saied, et al.
Publicado: (2021) -
Pasteurella multocida Vaccine Candidates: A Systematic Review
por: Mostaan, Saied, et al.
Publicado: (2020) -
Molecular heterogeneity of plpE gene in Indian isolates of Pasteurella multocida and expression of recombinant PlpE in vaccine strain of P. multocida serotype B: 2
por: Singh, Ajay Pratap, et al.
Publicado: (2010) -
Immunogenicity and protective efficacy of the recombinant Pasteurella multocida lipoproteins VacJ and PlpE, and outer membrane protein H from P. multocida A:1 in ducks
por: Li, Yajuan, et al.
Publicado: (2022) -
Recombinant-attenuated Salmonella enterica serovar Choleraesuis vector expressing the PlpE protein of Pasteurella multocida protects mice from lethal challenge
por: Zhou, Guodong, et al.
Publicado: (2023)